Segui
Pilar Alvarez
Pilar Alvarez
psiquiatra, Parc de Salut Mar
Email verificata su psmar.cat
Titolo
Citata da
Citata da
Anno
Detection of anxiety disorders in primary care: A meta‐analysis of assisted and unassisted diagnoses
E Olariu, CG Forero, JI Castro‐Rodriguez, MT Rodrigo‐Calvo, P Álvarez, ...
Depression and Anxiety 32 (7), 471-484, 2015
862015
Targeting Hormones for Improving Cognition in Major Mood Disorders and Schizophrenia: Thyroid Hormones and Prolactin.
SV Tost M, Monreal JA, Armario A, Barbero JD, Cobo J, García-Rizo C, Bioque ...
Clin Drug Investig. 40 (1), 1-14, 2020
592020
Altered [3H] imipramine and 5-HT2 but not [3H] paroxetine binding sites in platelets from depressed patients
P Rosel, B Arranz, J Vallejo, P Alvarez, JM Menchon, T Palencia, ...
Journal of affective disorders 52 (1-3), 225-233, 1999
531999
Early‐and late‐onset depression in the older: no differences found within the melancholic subtype
P Alvarez, M Urretavizcaya, L Benlloch, J Vallejo, JM Menchón
International journal of geriatric psychiatry 26 (6), 615-621, 2011
342011
Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain
P Rosel, JM Menchon, M Oros, J Vallejo, T Cortadellas, B Arranz, ...
Journal of neural transmission 104 (1), 89-96, 1997
281997
High affinity [3H] imipramine and [3H] paroxetine binding sites in suicide brains
P Rosel, B Arranz, J Vallejo, M Oros, JM Menchon, P Alvarez, MA Navarro
Journal of neural transmission 104, 921-929, 1997
261997
Platelet [3H] imipramine and [3H] paroxetine binding in depressed patients
P Rosel, JM Menchon, J Vallejo, B Arranz, MA Navarro, F Liron, P Alvarez
Journal of affective disorders 44 (1), 79-85, 1997
231997
Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder
Y Sánchez‐Carro, MJ Portella, I Leal-Leturia, N Salvat‐Pujol, M Etxandi, ...
Journal of Affective Disorders 279, 343-352, 2021
162021
Concurrent Koro and Cotard syndromes in a Spanish male patient with a psychotic depression and cerebrovascular disease
P Alvarez, VM Puente, MJ Blasco, P Salgado, A Merino, A Bulbena
Psychopathology 45 (2), 126-129, 2012
152012
Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning
Y Sánchez-Carro, A de la Torre-Luque, I Leal-Leturia, N Salvat-Pujol, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 121, 110674, 2023
132023
Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders
E Olariu, JI Castro-Rodriguez, P Álvarez, C Garnier, M Reinoso, ...
Quality of Life Research 24, 979-992, 2015
92015
Change in functioning outcomes as a predictor of the course of depression: a 12-month longitudinal study
CG Forero, E Olariu, P Álvarez, JI Castro-Rodriguez, MJ Blasco, G Vilagut, ...
Quality of Life Research 27, 2045-2056, 2018
82018
Asking patients about their general level of functioning: Is IT worth IT for common mental disorders?
E Olariu, CG Forero, P Alvarez, JI Castro-Rodriguez, MJ Blasco, J Alonso, ...
Psychiatry Research 229 (3), 791-800, 2015
82015
Relationship between immunometabolic status and cognitive performance among major depression disorder patients
Y Sánchez-Carro, A de la Torre-Luque, MJ Portella, I Leal-Leturia, ...
Psychoneuroendocrinology 137, 105631, 2022
62022
Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report
P Alvarez, E Papaseit, V Pérez, A Bulbena, M Farré
Actas Españolas de Psiquiatría 47 (1), 33-36, 2019
42019
Lithium: The survivor that came from the stars.
P Álvarez, P Salgado, V Pérez‐Solá
Bipolar Disorders 21 (5), 2019
22019
P. 0363 Relevance of immunometabolic status for the evaluation of cognitive performance in patients with major depressive disorder
Y Sánchez-Carro, A De la Torre-Luque, I Leal-Leturia, ...
European Neuropsychopharmacology 53, S264-S265, 2021
2021
Clinical severity and physical activity predict cognitive impairment in major depressive disorder.
Y Sánchez Carro, M Portella, I Leal Leturia, N Salvat, V Soria, P Alvarez, ...
European Psychiatry 63, 2020
2020
P. 611 Biomarkers of inflammation and neural plasticity in olfactory neuroepithelium-derived cells from patients with major depressive disorder
P Álvarez, JM Gines, C Fernández, A Toll, C Díez-Aja, LM Martín, ...
European Neuropsychopharmacology, 2019, vol. 29, supl. 6, p. S418-S419, 2019
2019
Alteración reversible del gusto y del olfato asociada con valproato sódico y quetiapina en la depresión bipolar: a propósito de un caso
P Álvarez López, E Papaseit Fontanet, V Pérez Solá, A Bulbena Vilarrasa, ...
Elsevier, 2019
2019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20